StockGuru Blog: The Immune Response Corporation – Multiple Sclerosis — NeuroVax(TM)/Autoimmune Diseases Phase IIb Clinical Trial
IMNR - The Immune Response Corporation StockGuru Profile IMNR The Immune Response Corporation (OTCBB:IMNR), is an immuno-pharmaceutical company, co-founded by Dr. Jonas Salk, developer of the polio vaccine. Stock Guru has scheduled several interviews with IMNR’s scientists and officers. The imminent launch of the 200-patient Phase IIb trial of NeuroVax(TM) will be a watershed event. This is a significant trial. Accelsiors, is a CRO with an outstanding track record with Multiple Sclerosis Phase II trials. Clinical investigators were recruited at sites in twelve Eastern and Central European countries selected because they offer some of the only sophisticated locations remaining with…